Last reviewed · How we verify
NCT05316194
Minimal Clinically Important Changes in Osteoarthritis Treatment
trial testing Digital treatment for hip and knee osteoarthritis in Osteoarthritis, Knee in 11,708 participants. Completed in 1 July 2021.
1 July 2021
Quick facts
| Lead sponsor | Joint Academy |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 11,708 |
| Start date | 6 June 2018 |
| Primary completion | 1 July 2021 |
| Estimated completion | 1 July 2021 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Digital treatment for hip and knee osteoarthritis
Conditions studied
- Osteoarthritis, Knee — all drugs for Osteoarthritis, Knee →
- Osteoarthritis, Hip — all drugs for Osteoarthritis, Hip →
Sponsor
Joint Academy
Who can join
18 and older, any sex, with Osteoarthritis, Knee or Osteoarthritis, Hip. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To assess minimal clinically important change, cut-offs for treatment failure and patient acceptable symptom state for pain and patient-reported function and quality of life in persons with hip or knee osteoarthritis, participating in digitally delivered first-line education and exercise treatment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Interpretation threshold values for patient-reported outcomes in patients participating in a digitally delivered first-line treatment program for hip or knee osteoarthritis.
Cronström A, Ingelsrud LH, Nero H, Lohmander LS, et al · · 2023 · cited 11× · PMID 37275788 · DOI 10.1016/j.ocarto.2023.100375
Verify or expand the search:
- PubMed search for NCT05316194
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Osteoarthritis, Knee
Currently open trials in the same condition.
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT06488144 — Rehabilitation for Arthritis of The Knee: mainTaining Improvement for Veterans · Phase 3 · recruiting
- NCT07386561 — Virtual Reality Therapy and Non-Sleep Deep Rest Relaxation After Joint Arthroplasty · NA · active not recruiting
- NCT07514598 — Effect of J-Shaped Incision After Total Knee Arthroplasty (J-TKA) · NA · active not recruiting
- NCT07058623 — Nurse-Led Telehealth vs In-Person Follow-Up After Total Knee Replacement · NA · recruiting
Other Joint Academy trials
Trials by the same sponsor.
- NCT05026580 — Outcomes During Digitally Delivered Osteoarthritis Treatment · withdrawn
- NCT06148779 — Can Digitally Delivered First-line Osteoarthritis Treatment Improve Equal Access to Care · recruiting
- NCT05402514 — Digitally Delivered Exercise and Education Treatment for Shoulder Pain: 3 Months Follow-up · completed
- NCT05499559 — Effects of 12-week Digital Treatment in Patients With Hand OA on Pain and Function · completed
- NCT05226156 — Digitally Delivered Exercise and Education Treatment for Low Back Pain: 3 Months Follow-up · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05316194 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Joint Academy
- Last refreshed: 17 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05316194.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing